April 22, 2021
The University of Oxford, Prenetics, a diagnostics and genetic testing company, and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to further develop OxLAMPTM technology, a molecular testing technology for infectious diseases.
Following the acquisition by Prenetics of Oxsed, an Oxford University spin-out company from October 2020, the aim has been to...
March 4, 2021
No-cost medications for patients in need. Online prescription discount platform GoodRx has partnered with the National Association of Free and Charitable Clinics (NAFC) to kick off a philanthropic program that will support patients in need with free prescriptions and care.
With a target goal of more than $5 million in free medications provided during 2021, the company said that it has kick-...
February 8, 2021
Late Friday, New York City-based health insurance company Oscar Health unveiled plans to kick off an initial public offering.
The tech-enabled company will list on the New York Stock Exchange under the symbol OSCR. Oscar temporarily listed the size of the offering as $100 million, although that value could change as the company hammers out the quantity of shares and price range it will be...
December 30, 2020
Through all of this year’s tumultuous ups and downs, one trend that has remained unstoppable – and has even accelerated – is the healthcare sector’s adoption of technology.
For years, MobiHealthNews has covered the payer space as it continually pushes further into the world of digital health, and 2020 proved no different. From traditional insurers embracing technology to massive expansions of...
December 22, 2020
Insurtech company Oscar has confidentially filed to go public, it announced Monday.
The New York City-based startup submitted a draft registration statement for its proposed initial public offering to the U.S. Securities and Exchange Commission, but the size and price range for the IPO has yet to be determined.
Oscar must now wait for the completion of the SEC review process before its IPO can be...
December 17, 2020
Oscar, a New York City-based health insurance technology company, has raised $140 million in a funding round announced just half a year after its last $225 million raise. The new investment was headed by Tiger Global Management, and also saw funds from Dragoneer, Baillie Gifford, Coatue, Founders Fund, Khosla, Lakestar and Reinvent.
WHAT IT DOES
Oscar describes itself as the "first-ever...
June 26, 2020
Health insurtech company Oscar Health scored a whopping $225 million in Series C funding from Google’s parent company Alphabet, General Catalyst, Khosla Ventures, Lakestar, Thrive Capital and Baillie Gifford.
This comes roughly two years after the company announced a $165 million funding round led by Brian Singerman and Founders Fund.
WHAT THEY DO
The company offers direct-to-consumer health...
June 15, 2016
Oscar Health’s step-tracking program isn’t just about improving member’s health, Holly Bui, Oscar's General Manager for California, said in a presentation at the MobiHealthNews 2016 event in San Francisco this week. It also improves members’ engagement with other offerings and helps keep a larger number of healthy people on the platform.
“What we found is that step tracking is a little bit...
March 3, 2016
So far this year, the digital health funding that MobiHealthNews tracked has surpassed $600 million. In January, digital health companies raised $471 million across 21 deals. This month, funding reached $197 million across 13 deals, although one of those deals was for an undisclosed amount.
More than half of February's funding came from one big deal: MindMaze raised $100 million. An honorary...
February 23, 2016
Late last month we wrote, based on a report from Fortune, that tech saavy up-and-coming health insurer Oscar was raising at least $150 million in a round led by Fidelity. That round is now confirmed, according to Forbes, and it's for more than initially reported: a total of $400 million. The deal reportedly values Oscar at $2.7 billion, just a bit shy of the $3 billion valuation Fortune predicted...